Skip to content

Balance and Executive Function in Middle-age and Older Patients With Heart Failure in Post-Acute Care Program

Balance and Executive Function in Middle-age and Older Patients With Heart Failure in Post-Acute Care Program

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06463496
Enrollment
60
Registered
2024-06-17
Start date
2024-06-17
Completion date
2026-02-28
Last updated
2026-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

Heart Failure, Balance Function, Executive Function

Brief summary

This trial is a single-center clinical trial in Taiwan with an expected enrollment of 60 people in Taiwan. The purpose of this trial is to compare the performance of middle-aged and elderly patients with subacute heart failure with that of a healthy control group in terms of balance function and executive function, as well as to investigate whether there is a correlation between balance function and executive function in middle-aged and elderly patients with heart failure and to track the changes in balance and executive function one month and three months after discharge from the hospital. Please think carefully before deciding whether to participate in this trial.

Interventions

None listed

Sponsors

Chang Chia-Jung
Lead SponsorOTHER
Kaohsiung Veterans General Hospital.
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with heart failure and receiving post-acute care program for heart failure * Left ventricular ejection fraction≦40% * Age ≥ 45 * No cognitive impairment * Ambulate independently or with the use of aids * Clinical symptoms are stable * Voluntary participation

Exclusion criteria

* Use of medications that cause dizziness or interfere with balance * Have other diagnoses that may affect balance, such as stroke, Parkinson's disease * Color blindness, severe hearing or visual impairment that prevents reading questions and listening to instructions

Design outcomes

Primary

MeasureTime frameDescription
Berg Balance ScaleT0 : Baseline ; T1: one month after discharge; T2: three months dischargeThe balance function will be evaluated using the Berg Balance Scale. Berg Balance Scale have 14 subtests, each of which is scored on a scale of 0 to 4, for a total score of 56, with higher scores indicating better balance.
Timed Up and Go TestT0 : Baseline ; T1: one month after discharge; T2: three months dischargeThe balance function will be evaluated using the Timed Up and Go Test. Timed Up and Go Test use a chronograph to measure the total time spent (in seconds), with less time representing better ability.

Secondary

MeasureTime frameDescription
Color Trails TestT0 : Baseline ; T1: one month after discharge; T2: three months dischargeThe Working memory will be evaluated using Color Trails Test. Scoring is based on the total number of seconds to complete the test. Lower scores represent greater difficulty inWorking memory .
The Stroop Color and Word TestT0 : Baseline ; T1: one month after discharge; T2: three months dischargeThe Inhibitor Control will be evaluated using the Stroop Color and Word Test. The test consisted of three parts, each spanning 45 s where participants read out as many colour words such as ''red, green, blue and purple'' or coloured items words as possible. Number of items corrected and wrongly read out were used to compute the predicted colour-word (Pcw) and interference (IF).Lower scores represent greater difficulty in inhibiting incongruence.
Digit Span TestT0 : Baseline ; T1: one month after discharge; T2: three months dischargeThe Cognitive flexibility will be evaluated using the Digit Span test. The scores range from 0 to 45. Lower scores represent greater difficulty in Cognitive flexibility .

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026